These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 38013718)

  • 21. Nanotechnology against COVID-19: Immunization, diagnostic and therapeutic studies.
    Hasanzadeh A; Alamdaran M; Ahmadi S; Nourizadeh H; Bagherzadeh MA; Mofazzal Jahromi MA; Simon P; Karimi M; Hamblin MR
    J Control Release; 2021 Aug; 336():354-374. PubMed ID: 34175366
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Global Trends in Nursing-Related Research on COVID-19: A Bibliometric Analysis.
    Zhang Q; Li S; Liu J; Chen J
    Front Public Health; 2022; 10():933555. PubMed ID: 35923953
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nanotechnology: an emerging approach to combat COVID-19.
    Chintagunta AD; M SK; Nalluru S; N S SK
    Emergent Mater; 2021; 4(1):119-130. PubMed ID: 33615141
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Global Scientific Research on SARS-CoV-2 Vaccines: A Bibliometric Analysis.
    Rahim F; Khakimova A; Ebrahimi A; Zolotarev O; Rafiei Nasab F
    Cell J; 2021 Oct; 23(5):523-531. PubMed ID: 34837679
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nanotechnology as a Shield against COVID-19: Current Advancement and Limitations.
    Rai M; Bonde S; Yadav A; Bhowmik A; Rathod S; Ingle P; Gade A
    Viruses; 2021 Jun; 13(7):. PubMed ID: 34202815
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mapping the technological landscape of SARS, MERS, and SARS-CoV-2 vaccines.
    Nascimento Júnior JAC; Santos AM; Cavalcante RCM; Quintans-Júnior LJ; Walker CIB; Borges LP; Frank LA; Serafini MR
    Drug Dev Ind Pharm; 2021 Apr; 47(4):673-684. PubMed ID: 33826439
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Coronavirus Disease 19 (COVID-19) Vaccine Effectiveness Against Symptomatic Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection During Delta-Dominant and Omicron-Dominant Periods in Japan: A Multicenter Prospective Case-control Study (Factors Associated with SARS-CoV-2 Infection and the Effectiveness of COVID-19 Vaccines Study).
    Arashiro T; Arima Y; Muraoka H; Sato A; Oba K; Uehara Y; Arioka H; Yanai H; Kuramochi J; Ihara G; Chubachi K; Yanagisawa N; Nagura Y; Kato Y; Ueda A; Numata A; Kato H; Ishii K; Ooki T; Oka H; Nishida Y; Stucky A; Smith C; Hibberd M; Ariyoshi K; Suzuki M
    Clin Infect Dis; 2023 Feb; 76(3):e108-e115. PubMed ID: 35918782
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biomimetic Nanotechnology for SARS-CoV-2 Treatment.
    Li S; Liu X; Liu G; Liu C
    Viruses; 2023 Feb; 15(3):. PubMed ID: 36992304
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nanomedicine for the SARS-CoV-2: State-of-the-Art and Future Prospects.
    Varahachalam SP; Lahooti B; Chamaneh M; Bagchi S; Chhibber T; Morris K; Bolanos JF; Kim NY; Kaushik A
    Int J Nanomedicine; 2021; 16():539-560. PubMed ID: 33519200
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Toward Nanotechnology-Enabled Approaches against the COVID-19 Pandemic.
    Weiss C; Carriere M; Fusco L; Capua I; Regla-Nava JA; Pasquali M; Scott JA; Vitale F; Unal MA; Mattevi C; Bedognetti D; Merkoçi A; Tasciotti E; Yilmazer A; Gogotsi Y; Stellacci F; Delogu LG
    ACS Nano; 2020 Jun; 14(6):6383-6406. PubMed ID: 32519842
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Comprehensive Review on COVID-19: Emphasis on Current Vaccination and Nanotechnology Aspects.
    Rai A; Shah K; Sharma R; Dewangan HK
    Recent Pat Nanotechnol; 2023; 17(4):359-377. PubMed ID: 35986540
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Diagnosis, treatment, control and prevention of SARS-CoV-2 and coronavirus disease 2019: back to the future].
    Ye ZW; Jin DY
    Sheng Wu Gong Cheng Xue Bao; 2020 Apr; 36(4):571-592. PubMed ID: 32347053
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aspects of Nanotechnology for COVID-19 Vaccine Development and Its Delivery Applications.
    Prabhakar PK; Khurana N; Vyas M; Sharma V; Batiha GE; Kaur H; Singh J; Kumar D; Sharma N; Kaushik A; Kumar R
    Pharmaceutics; 2023 Jan; 15(2):. PubMed ID: 36839773
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A bibliometric analysis of the 100 most cited articles describing SARS-CoV-2 variants.
    Zhang Y; Feng M; He Y; Liu F; Ma R
    Front Public Health; 2022; 10():966847. PubMed ID: 36091553
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cardiac Involvement in COVID-19: A Global Bibliometric and Visualized Analysis.
    Xu SC; Zhao XY; Xing HP; Wu W; Zhang SY
    Front Cardiovasc Med; 2022; 9():955237. PubMed ID: 35966543
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Twenty-Year Span of Global Coronavirus Research Trends: A Bibliometric Analysis.
    Zhou Y; Chen L
    Int J Environ Res Public Health; 2020 Apr; 17(9):. PubMed ID: 32354181
    [TBL] [Abstract][Full Text] [Related]  

  • 37. COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.
    Meo SA; Bukhari IA; Akram J; Meo AS; Klonoff DC
    Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1663-1669. PubMed ID: 33629336
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Trend of Polymer Research Related to COVID-19 Pandemic: Bibliometric Analysis.
    Chiari W; Damayanti R; Harapan H; Puspita K; Saiful S; Rahmi R; Rizki DR; Iqhrammullah M
    Polymers (Basel); 2022 Aug; 14(16):. PubMed ID: 36015553
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SARS-CoV-2 and COVID-19 Research Trend during the First Two Years of the Pandemic in the United Arab Emirates: A PRISMA-Compliant Bibliometric Analysis.
    Al-Omari B; Ahmad T; Al-Rifai RH
    Int J Environ Res Public Health; 2022 Jun; 19(13):. PubMed ID: 35805413
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.
    Conti P; Caraffa A; Gallenga CE; Kritas SK; Frydas I; Younes A; Di Emidio P; Tetè G; Pregliasco F; Ronconi G
    J Biol Regul Homeost Agents; 2021; 35(1):1-4. PubMed ID: 33377359
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.